Compound ID | 591
Class: Antivirulence agent
| Agent Type: | Synthetic; Small molecule; Direct acting; Antivirulence; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Antivirulence agent; two-component system inhibitor |
| Target Pathogen: | Active against multidrug-resistant Staphylococcus aureus and Enterococcus faecium |
| Description: | Derivative of RWJ-49815; Melton JL, Fernandez JA, Frechette RF, et al. In vivo activity of a novel series of antibacterial agents that inhibit the bacterial two component signal transduction system. 37th-Intersci-Conf-Antimicrobial-Agents-Chemother 1997; 185. |
| Institute where first reported: | Johnson & Johnson Pharmaceutical R&D, USA |
| Year first mentioned: | 1997 |
| Development status: | Experimental |
| Reason dropped: | Provided no protection to mice |
| External links: | |
| Citation: | https://doi.org/10.1073/pnas.95.9.5317 |